AGS67E

· Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AGS67E, covering 2024-11-01 to 2024-11-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML) [Phase 1]

See pricing